Rheumatology Therapeutics Market Size, Share, Growth Report 2032

Global Rheumatology Therapeutics Market Overview     

The global Rheumatology Therapeutics market accounted for USD 48.4 Billion in 2020 and is expected to reach USD 64.4 Billion by 2028, growing at a CAGR of 3.1% from 2021 to 2028.  

Musculoskeletal conditions are a major burden on the individual, society and the healthcare service providers. These conditions result in joint inflammation, pain, swelling, and stiffness. Rheumatic disease is one of the leading causes of morbidity in around the world. People of all ages, genders, and races can have arthritis, and it is the leading cause of disability in the United States. More than 50 Billion adults and almost 300,000 children have arthritis or some other type of rheumatic disease. Rheumatic diseases are generally common among women and occur more frequently as people get older.

COVID-19 Impact Analysis:

The global Rheumatology Therapeutics market has witnessed a significant growth during the COVID-19 pandemic. The pandemic is having an unprecedented effect on daily lives and this has impacted every single sector and the global economy. However, the demand for Rheumatology Therapeutics is growing exponentially during the pandemic, as the value of digital approaches which are designed to help health professionals and the public stay up to date about the disease, allow better strategic planning, and maintain communication are now rapidly being highlighted and adopted.

The market would remain bullish in upcoming year.  

Request Free Sample

Growth Factors

The growing burden of rheumatic diseases around the world is fostering the growth of rheumatology therapeutics market. A wide number of biosimilars and drugs under pipeline are fostering the growth of the market. However, high capital investments in drug development, stringent rules and regulations are slowing the growth of the market. Technologically enhanced products such as biologics and biosimilars are expected to present lucrative business opportunities in future.

Report Scope:

Segment Analysis Preview  

On the basis of disease type, the global rheumatology therapeutics market is divided into rheumatoid arthritis, osteoarthritis, lupus, gout, ankylosing spondylitis and other. Rheumatoid arthritis disease has high prevalence rates than other disease and accounts for the major share in global rheumatology therapeutics market.  

On the basis of drug type the market is segmented into non-steroidal anti-inflammatory drugs, analgesics, disease modifying anti-rheumatic drugs, corticosteroids and other. DMARDs segment dominated the market in 2016 owing to their increased in use in the early stage of treatment. The distribution channel segment of rheumatology therapeutics includes a retail pharmacy, online pharmacy, and hospitals.

Request Free Sample

Regional Analysis Preview  

The global rheumatology therapeutics market was dominated by North America and it held a maximum share of total revenue generated in 2020. The growth in this region is attributed to the increased geriatric population and soaring capital investments in the pharma sector. Europe is another leading regional market followed by North America. Growing incidences of rheumatoid diseases and advanced healthcare infrastructure is accounting the growth in this region. The Asia Pacific is the fastest growing market and is expected to show strong growth in the forecast period. The growth in this region is primarily driven due to increasing geriatric population in countries like China and India. Japan is also accounting for a key share in Asia Pacific market owing to the presence of elderly population. Latin America is an emerging market due to rising healthcare infrastructure in this region.

Key Market Players & Competitive Landscape

Some of key players in Rheumatology Therapeutics Market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Takeda Pharmaceutical and Sanofi among others.

Request Free Sample

The global Rheumatology Therapeutics Market is segmented as follows:   

By Disease Type

• Rheumatoid Arthritis
• Ankylosing spondylitis
• Osteoarthritis
• Lupus
• Gout
• Other

By Drug Type

• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)     
• Analgesics  
• Disease Modifying Anti-Rheumatic Drugs (DMARDs)      
• Corticosteroids
• Others

By Distribution Channel

• Retail Pharmacy       
• Online Pharmacy        
• Hospitals       
• Other       

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa